EyePoint Pharmaceuticals (EYPT) Stock Highlights

8.96 | -2.71%

2024-11-21 04:06:39

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert and Verisome Technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Statistics

Range Today

8.7 9.15

Volume Today 1.56M

Range 1 Year

5.86 30.99

Volume 1 Year 277.91M

Range 3 Year

2.19 30.99

Volume 3 Year 460.71M

Range 10 Year

2.19 58.1

Volume 10 Year 625.24M

Highlights

Market Capitalization 793.76M (small)

Floating Shares 39.65M

Current Price 8.96

Price To Earnings -6.47

Price To Revenue 7.73

Price To Book 2.14

Earnings Per Share -1.79

Payout Ratio 0%

Performance

Latest -2.71%

1 Month -18.77%

3 Months +13.13%

6 Months -24.32%

1 Year +34.74%

3 Years -47.2%

5 Years -35.07%

10 Years -75.38%

Benchmarks

Market Capitalization

104 / 368

Gross Profits

78 / 278

Total Revenue

131 / 300

Total Rank

123 / 368

Free Cashflow

24 / 352

Performance 5 years

158 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.